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Abstract 
Anticoagulant rodenticide (AR) resistance in Norway rat populations has been a problem for fifty years, 
however its impact on non-target species, particularly predatory and scavenging animals has received 
little attention. Field trials were conducted on farms in Germany and England where resistance to 
anticoagulant rodenticides had been confirmed. Resistance is conferred by different mutations of the 
VKORC1 gene in each of these regions: tyrosine139cysteine in Germany and leucine120glutamine in 
England. A modelling approach was used to study the transference of the anticoagulants into the 
environment during treatments for Norway rat control. Baiting with brodifacoum resulted in lower levels 
of AR entering the food chain via the rats and lower numbers of live rats carrying residues during and 
after the trials due to its lower application rate and efficacy against resistant rats.  Bromadiolone and 
difenacoum resulted in markedly higher levels of AR uptake into the rat population and larger numbers 
of live rats carrying residues during the trials and for long periods after the baiting period. Neither 
bromadiolone nor difenacoum provided full control on any of the treated farms.  In resistant areas where 
ineffective compounds are used there is the potential for higher levels of AR exposure to non-target 
animals, particularly predators of rats and scavengers of rat carcasses. Thus, resistance influences the 
total amount of AR available to non-targets and should be considered when dealing with rat infestations, 
as resistance-breakers may present a lower risk to wildlife. 
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Introduction 
Anticoagulant rodenticides (ARs) are used globally to control pest rodent infestations. Resistance to ARs 
first appeared against warfarin and diphacinone in Scotland in 1958 (Boyle, 1960). In the wake of this, 
more potent ARs were produced but resistance has since developed to some of these (RRAG, 2010). 
Monitoring residues in carcasses of predators and scavengers in the UK has shown that ARs may affect a 
range of non-target species, including some of high conservation value (Burn and Carter, 2002; Shore et 
al., 2005). The risk to wildlife depends on several factors, including AR loading in individual rats and 
total AR residue in rat populations. The impact of resistance on these factors is less well understood. 
Resistant rats are able to consume some rodenticides without dying and so may carry body burdens of 
active substance at higher levels and for longer than rats that are susceptible to the poisons (Atterby et al. 
2005; Brakes and Smith, 2005). Using data from field trials against resistant rats and modelling the 
movement of active substance in the rat population we show that this is indeed the case and rodenticide-
resistant areas could be a particular hazard with regard to non-target exposure. 
Materials and methods 
Field trials of three ARs (brodifacoum, bromadiolone and difenacoum) were conducted on farms in 
North-west Germany and Southern England between 2005 and 2010 where resistance to bromadiolone 
and difenacoum in Norway rats (Rattus norvegicus) was confirmed. Rat population censuses were 
carried out pre- and post-baiting. AR baits were applied according to product labels, pulsed-baiting was 
used for brodifacoum and surplus baiting for bromadiolone and difenacoum (Buckle, 1994). All baits 
contained 0.005% w/w of the respective active substances. A model was created utilizing the data 
obtained from these trials to predict the amounts of the AR active substances in different environmental 
compartments through the course of the trials. 
Results 
Across all trials brodifacoum was the most effective compound reducing rat populations to less than 1% 
of their original size. Bromadiolone and difenacoum had lower rates of success as would be expected in 
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resistant areas (29% reduction to population growth and 13-84% reduction per farm respectively). Our 
model showed that bromadiolone and difenacoum use in these trials resulted in much higher levels of AR 
entering the food chain via the rats than the use of brodifacoum (Figure 1). It also showed that AR 
continued to enter the rat population at a much higher rate throughout the trials where control was less 
effective. The model predicted that after the end of baiting live rats carrying residues of AR were present 
for more than 10 times as long for bromadiolone and difenacoum trials than for brodifacoum trials. 
 
Fig. 1 Mean amounts of anticoagulants taken up by rat populations baited with each compound: bromadiolone 
(BMD, n=6 trials), difenacoum (DIF, n=4) and brodifacoum (BDF, n=2), over the whole farm.  BMD 
and DIF trials showed much higher uptakes over the course of the trials than BDF trials. 
Discussion 
The use of potent AR ‘resistance-breakers’ (including brodifacoum and flocoumafen) is sometimes 
avoided due to their higher toxicity and potential to be more hazardous in the environment (Eason et al., 
2002). However in areas where practitioners seek to control resistant rodent infestations, their use may 
pose less of a risk than applications of ineffective baits. Compounds to which rodents are resistant to do 
not provide effective control and create a long-term source of AR to enter the environment. The higher 
quantities of AR used show that using ineffective compounds may extend both the period and severity of 
exposure to non-target animals to ARs. Conversely the use effective use of resistance-breakers to control 
anticoagulant rodenticide-resistant rat populations results in lower environmental exposure of ARs for 
non-targets. Of course, the relative toxicity of the different ARs will also play an important part in 
overall risk assessments. 
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